Cite
HARVARD Citation
Welzel, T. et al. (2017). Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry. Journal of viral hepatitis. 24 (10), pp. 840-849. [Online].